NeoMedica, a world-renowned manufacturer for more than 20 years, guarantees and offers quality, innovation and excellence of in vitro diagnostic medical devices.

NeoMedica’s hematology, biochemistry and immunology reagents and devices are used by satisfied customers in more than 80 countries worldwide, making it one of the largest brands in this field.

In its business, NeoMedica focuses on continuous investment in innovative technologies and products, providing reliable solutions adapted to users.



  • Automated Monotest Immunoanalyzers NAISSA / UNI/ COPROSS; Immunology tests in a reagent monotest cartidge form
  • Hematology analyzers and hematology reagents
  • Clinical chemistry analyzers and reagents
  • Urine analyzers, immunochromatograpic urine test strips
  • ISE analyzers
  • NeoCare: Clean & Protect Disinfectants

Production capacities:

  • The maximum annual production capacity of immunochemical tests is 89100 boxes.
  • The maximum annual production capacity of the devices is 1080 analyzers.
  • The maximum annual production capacity of reagents is 2,625 tons.

Export markets:

  • Europe (Italy, Bulgaria, Croatia, North Macedonia, Romania, Hungary, Albania, Greece, Czech Republic, Italy, Lithuania, Bosnia, Portugal, Spain, Ukraine…)
  • Africa (Egypt, Botswana, Congo, Uganda, Kenya, Mauritania, Libya, Algeria, Morocco, Burkina Faso, Togo, Ghana, Nigeria, Sudan, Ivory Coast, Botswana, Mauritius, Tunisia)
  • Asia (Vietnam, Bangladesh, UAE, Qatar, Bahrain, Israel, Indonesia, Philippines, Thailand, Yemen, Saudi Arabia, Jordan, Lebanon, Syria)
  • America (Bolivia, Urugvay, Chile, Equador, Guyana, Guatemala)

Standards and certifications: ISO 13485, ISO 9001

A: Bulevar sv cara Konstantina 82-86, 18000 Niš, Serbia
P: +381 18 573 822
M: +381 63 10 60 844